COLL 8-K 2026-10-19

COLLEGIUM PHARMACEUTICAL, INC (COLL) 8-K dated 2026-10-19 — accession 0001104659-26-116876. This URL is the filing, not the COLL hub.

COLLEGIUM PHARMACEUTICAL, INC (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.

COLLEGIUM PHARMACEUTICAL, INC filed a 8-K on 2026-10-19. Accession 0001104659-26-116876.

Cached items: 1.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported COLL revenue for 2026-06-30 was $199.9M. Net income was -$15.1M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. COLL currently screens at market cap $1.12B.

Not investment advice. The COLL SEC hub lists recent forms. The stock page is the research view.